Quick Answer
cbdMD, Inc. reported Stockholders Equity of $7.23 million for the year ending 2025.
- cbdMD, Inc. showed an increase of +268.0% in Stockholders Equity from 2024 to 2025.
- This data is from cbdMD, Inc.'s annual report (Form 10-K), filed with the SEC on December 19, 2025.
- XBRL data for this metric is available from 2018 to 2025 (26 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $13.35 million | Q1 2018: $14.16 million | Q2 2018: $13.81 million | Q4 2023: $7.04 million | Q1 2024: $3.09 million | Q2 2024: $3.03 million | Q3 2024: $1.96 million | Q4 2024: $1.78 million | Q1 2025: $665.8 thousand | Q2 2025: $6.11 million | Q3 2025: $7.23 million | Q4 2025: $9.01 million.
- Over the full 26 years of available data (2018 to 2025), cbdMD, Inc.'s Stockholders Equity has declined by 42.7%.
- Historical annual values: Fiscal year 2025: $7.23 million | Fiscal year 2024: $1.96 million | Fiscal year 2024: $3.03 million | Fiscal year 2024: $3.09 million | Fiscal year 2023: $7.04 million | Fiscal year 2023: $9.03 million | Fiscal year 2023: $25.73 million | Fiscal year 2023: $25.79 million | Fiscal year 2022: $26.59 million | Fiscal year 2022: $31.42 million | Fiscal year 2022: $46.60 million | Fiscal year 2022: $80.02 million | Fiscal year 2021: $84.40 million | Fiscal year 2021: $103.14 million | Fiscal year 2021: $89.28 million | Fiscal year 2021: $85.88 million | Fiscal year 2020: $85.72 million | Fiscal year 2020: $79.18 million | Fiscal year 2020: $83.58 million | Fiscal year 2020: $92.16 million | Fiscal year 2019: $55.52 million | Fiscal year 2019: $37.60 million | Fiscal year 2019: $25.15 million | Fiscal year 2019: -$13.45 million | Fiscal year 2018: $18.13 million | Fiscal year 2018: $12.61 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: